Variant report
Variant | esv3436415 |
---|---|
Chromosome Location | chr1:56623664-56625062 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188294011 | chr1:56623677-56623678 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572336000 | chr1:56623749-56623750 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535034807 | chr1:56623766-56623767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557945424 | chr1:56623779-56623780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs578052293 | chr1:56623785-56623786 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574976067 | chr1:56623795-56623796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113143981 | chr1:56623875-56623876 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs778386 | chr1:56623915-56623916 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs542897210 | chr1:56623973-56623974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs560011267 | chr1:56623984-56623985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531248282 | chr1:56623989-56623990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs182966449 | chr1:56623991-56623992 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547943135 | chr1:56623993-56623994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1304824 | chr1:56624014-56624015 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs564786586 | chr1:56624015-56624016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs530609977 | chr1:56624027-56624028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188063949 | chr1:56624041-56624042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570986550 | chr1:56624085-56624086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs778387 | chr1:56624095-56624096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371164664 | chr1:56624109-56624110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs28546152 | chr1:56624119-56624120 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
22 | rs201942614 | chr1:56624120-56624121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12025709 | chr1:56624128-56624129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs12025723 | chr1:56624130-56624131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529952519 | chr1:56624131-56624132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11485599 | chr1:56624132-56624133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373508134 | chr1:56624139-56624140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375515061 | chr1:56624141-56624142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376201448 | chr1:56624143-56624144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs28678508 | chr1:56624150-56624151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12025729 | chr1:56624165-56624166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191451416 | chr1:56624287-56624288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183653263 | chr1:56624333-56624334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536102555 | chr1:56624350-56624351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534664104 | chr1:56624382-56624383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs539506254 | chr1:56624389-56624390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111403171 | chr1:56624425-56624426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4926710 | chr1:56624427-56624428 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs541505502 | chr1:56624428-56624429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537145329 | chr1:56624462-56624463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34506922 | chr1:56624466-56624467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146878147 | chr1:56624479-56624480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187968594 | chr1:56624525-56624526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72912224 | chr1:56624556-56624557 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs553342579 | chr1:56624567-56624568 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs573489010 | chr1:56624585-56624586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545416388 | chr1:56624597-56624598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145628611 | chr1:56624667-56624668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115476456 | chr1:56624744-56624745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs544311150 | chr1:56624747-56624748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Papillary thyroid carcinoma | 21436994 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Meckel-Gruber syndrome | 21572526 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19490664 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:56619400-56624800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr1:56621400-56624000 | Enhancers | Dnd41 | blood |
3 | chr1:56622400-56624000 | Enhancers | Fetal Thymus | thymus |
4 | chr1:56622600-56623800 | Enhancers | Thymus | Thymus |
5 | chr1:56622600-56624000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr1:56622600-56624000 | Enhancers | Primary T cells from cord blood | blood |
7 | chr1:56623400-56624600 | Weak transcription | Placenta Amnion | Placenta Amnion |
8 | chr1:56623600-56626400 | Weak transcription | Fetal Kidney | kidney |
9 | chr1:56623800-56624800 | Weak transcription | Thymus | Thymus |
10 | chr1:56624000-56624400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr1:56624400-56625400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr1:56624600-56625000 | Enhancers | Placenta Amnion | Placenta Amnion |
13 | chr1:56624600-56625200 | Enhancers | Right Atrium | heart |
14 | chr1:56624800-56625000 | Enhancers | Thymus | Thymus |
15 | chr1:56624800-56625200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr1:56625000-56633000 | Weak transcription | Placenta Amnion | Placenta Amnion |